SARS-CoV-2 vaccinations are accelerating across the U.S. with approximately 66 million first doses having been administered as of February 25th, representing 13.6% of the country, according to NPR. The vaccination effort received another boost with the Food and Drug Administration’s recent Emergency Use Authorization (EUA) of Johnson & Johnson’s (J&J) single-dose vaccine.
Image: https://biobuzz.io
The 12-year-old George Mason University spinout has taken over 12,000 more square feet, not far from its headquarters.
Image: Ross Dunlap is co-founder and CEO of Ceres Nanosciences. COURTESY ROSS DUNLAP
Montgomery College and the Universities at Shady Grove (USG), in conjunction with the University of Maryland, Baltimore County (UMBC), have completed two intensive pilot training programs designed to create a skilled talent pipeline to support the life sciences sector in Montgomery County. The four-week “Bio Boot Camp” program—a public-private effort announced in November 2020—was created to help kickstart recovery from the COVID-19 health crisis.
Image: https://montgomerycomd.blogspot.com
The entrepreneurs behind an exited Baltimore biotech company are creating a new center for immigration law in the city.
A $5 million gift from Marco and Debbie Chacón to the University of Maryland Francis King Carey School of Law will help to establish the Baltimore-based school’s new Chacón Center for Immigrant Justice.
The couple founded Paragon Bioservices, the contract manufacturing and development company that was acquired by Catalent in 2019 for $1.2 billion. Marco Chacón served as CEO and Debbie Chacón served as VP when the company moved to the University of Maryland BioPark in 2009. Now known as Paragon Gene Therapy, it still has a base at the BioPark, and Marco Chacón founded Irazú Bio, which is also based in the BioPark.
Image: Marco and Debbie Chacón founded Paragon Bioservices. (Photo courtesy of University of Maryland School of Law)
All eyes are on the global rollout of COVID-19 vaccines. Achieving the broad uptake needed to reach population immunity and curb the virus’s spread will require an unprecedented effort among health workers, scientists and stakeholders at every step of the supply chain.
During this 90 min event, experts from organizations central to vaccine development and delivery, regulatory oversight and quality assurance will discuss over the course of two high-level panels what’s needed for the global COVID-19 vaccination campaign, how to build public trust in the quality and effectiveness of vaccines, and how these investments can build better systems for the future.
BALTIMORE (WJZ) — As students and staff return to the classroom, state leaders are working to get every teacher vaccinated. Now, there’s a way to track the progress.
Johns Hopkins University is launching its teacher vaccination tracker.
Image: https://baltimore.cbslocal.com – From Video
COLUMBIA, Md. (March 8, 2021)—TEDCO, Maryland’s economic engine for technology companies, announced today its Seed Fund invested $400,000 in two technology start-ups. TEDCO’s Seed Fund invests in early-stage, technology and life sciences companies and includes gap financing.
A free, virtual Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond, presented by EAGB & BHI.
The Economic Alliance of Greater Baltimore (www.greaterbaltimore.org) and BioHealth Innovation (www.biohealthinnovation.org) have partnered to host a Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond. The Forum is free and will be held virtually on March 25, from1 – 3:00 pm. There is no fee and all are welcomed, but you must register in order to receive the link to the event.
The Digital Health Forum features two panel discussions and a moderated conversation. Brief welcome comments by Rich Bendis and Michele Whelley, CEO of BHI and EAGB, respectively, will open the Forum.
Visit https://bit.ly/DigitalHealth21 to learn more and register for this FREE Event today.
Sponsored by: First National Bank, Olive, and TEDCO
A free, virtual Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond, presented by EAGB & BHI.
The Economic Alliance of Greater Baltimore (www.greaterbaltimore.org) and BioHealth Innovation (www.biohealthinnovation.org) have partnered to host a Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond. The Forum is free and will be held virtually on March 25, from1 – 3:00 pm. There is no fee and all are welcomed, but you must register in order to receive the link to the event.
The Digital Health Forum features two panel discussions and a moderated conversation. Brief welcome comments by Rich Bendis and Michele Whelley, CEO of BHI and EAGB, respectively, will open the Forum.
Visit https://bit.ly/DigitalHealth21 to learn more and register for this FREE Event today.
Sponsored by: First National Bank, Olive, and TEDCO
Shares of Altimmune Inc. ALT were down 4.8% in trading on Thursday after the company said it started enrolling participants in a Phase 1 clinical trial for its COVID-19 vaccine candidate. Altimmune is developing a single-dose nasal spray vaccine. The study is expected to enroll up to 180 healthy adults between the ages of 18 and 55 years old, who will receive one of three doses of the experimental vaccine. The company said it expects to share the first batch of clinical data from this trial in the second quarter of this year. Altimmune’s stock has soared 969.9% over the past 12 months, while the broader S&P 500 SPX is up 21.7%.
